GENETIC ADDICTION RISK ANALYSIS FOR RDS SEVERITY INDEX

Patent №

US 10,072,289

Granted

2018-09-11

Filed 2015

Owner

SYNAPTAMINE, INC.

+4 more

Lab

AI components

1

ml

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

14796989

Methods and kits for assessing severity index for alcohol abuse, drug abuse, and other reward deficiency syndromes. It has been discovered that a multifaceted non-specific RDS behaviors should be considered as the true “reward” phenotype (endophenotype) instead of a single subset RDS behavior such as alcoholism. In an embodiment of the present invention, it has been discovered that there are at least eleven risk alleles associated with ten candidate genes. The methods and kits of the present invention satisfy the need to classify patients at genetic risk for drug/alcohol seeking behavior prior to or upon entry to residential and or non-residential chemical dependency and pain programs.

Machine learningC12Q 1/6827C12Q 1/6883G16B 20/00G16B 20/20G16B 25/00G16B 25/10G16B 30/00G16B 40/00+7 more

AI classification

Machine learning0.66
Vision0.46
AI hardware0.07
Natural language0.07
Knowledge representation0.01
Planning0.00
Evolutionary computation0.00
Speech0.00

Ownership

SYNAPTAMINE, INC.

assignment · 362330970

IGENE LLC

assignment · 402310171

GENEUS HEALTH LLC

assignment · 503830232

GENEUS HEALTH IP, LLC

assignment · 511540386

IVITALIZE IP HOLDINGS, INC.

assignment · 596950609

Assignors

BLUM, KENNETH

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC